Abstract:OBJECTIVES:To examine p53 codon 72 polymorphism in cervical cancers and its correlation with HPV16/18 E6.METHODS:Cervical specimens were taken from 81 patients with cervical squamous cancer, 18 patients with cervical adenocarcinoma, 88 patients with CIN II - III and 60 patients without cancers. PCR was used to examine the p53 genotypes and the expression of HPV16 and 18 E6.RESULTS:The frequencies of p53 Arg homozygosity in cervical squamous cancer, cervical adenocarcinoma and CIN (II - III) were 58.020%, 55.55% and 59.09% respectively, greater than those of p53 Arg/Pro heterozygosity (30.86%, 27.78%, 21.59%) and those of p53 Pro homozygosity (11.12%, 16.67%, 19.32%). The normal cervical samples also showed less frequency of p53 Arg homozygosity (23.33%) than cervical squamous cancer. There were no significant differences in the frequencies of p53 Arg homozygosity, p53 Arg/Pro heterozygosity and p53 Pro homozygosity (23.33%, 40.00% and 36.67% respectively). The frequency of HPV16,18 E6-positive in cervical cancer and CIN was much higher than that in control group (81.84%, 50.00% and 53.41%) for the normal cervical samples. The expression of HPV16 and 18 E6 in cervical squamous cancers was more frequent than in CIN. The frequency of p53 Arg homozygosity in HRHPV E6-positive cervical squamous cancers (64.06%) was greater than in HRHPV E6-negative cervical squamous cancers (35.29%) and in HRHPV E6-positive normal samples (33.33%). The p53 codon 72 polymorphism showed no differences in samples with different FIGO staging and grades.CONCLUSION:p53 Arg homozygosity could serve as a risk indicator for the tumorigenesis of cervix. In combination with HRHPV E6, it might be able to predict the progression of cervical lesions. p53 codon 72 polymorphism is not associated with FIGO staging and grades of cervical cancers.

The relationship between P53 over-expression and micronuclei in cancerous and precancerous lesion of oral mucosa

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

Involvement of P53 Mutation and Mismatch Repair Proteins Dysregulation in NNK-Induced Malignant Transformation of Human Bronchial Epithelial Cells

[Expressions of PDCD5 and P53 in Oral Leukoplakia and Oral Squamous Cell Carcinoma].

Relationship Between P21,p53 Expression and Single Nucleotide Polymorphism with Hepatocellular Carcinoma

Expressions of p53 and hMSH2 in colon carcinoma

[Detection of P53 Mutation Using PCR-SSCP Silver Staining Method].

[Alterations of P53 Gene and Microsatellite Instability in Ulcerative Colitis and Ulcerative Colitis-Associated Colorectal Cancer].

Association of Micronuclear Frequency with Dysplasia and Cytogenetic Changes (p53 Mutation and p16 Expression) in Oral Potentially Malignant Disorders

[Human Papillomavirus, Human Cytomegalovirus and P53 Gene in Cervical Carcinoma].

[Meta-Analysis on the Relationship Between Tobacco Smoking, Alcohol Drinking and P53 Alteration in Cases with Esophageal Carcinoma].

[Expression and correlation of HPV16E6 and tumor suppressor gene p53 in oral squamous cell carcinoma]

The Expression of P16, P53 and Ki-67 Protein in Epithelial Dysplasia from Oral Mucosa and a Follow-Up Study of Four Years

P53 Codon 72 Polymorphism in Cervical Cancers and Its Correlation with HPV16,18E6

P53 Gene Mutations in Surgical Margins with Esophageal Squamous Cell Carcinoma

The Clinical Significance of Detection of P53 Gene Mutation in Patients with Lung Cancer

Mutagen Sensitivity and P53 Expression in Colorectal Cancer in China.

p53-positive expression in dysplastic surgical margins is a predictor of tumor recurrence in patients with early oral squamous cell carcinoma.

Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.